- Home
- Companies
- Hemex Health
- Products
- Hemex Health - Gazelle Diagnostic ...
Hemex Health - Gazelle Diagnostic Device
Hemex Health is working to empower the frontlines of healthcare with our inexpensive, portable, and easy-to-use diagnostic device - Gazelle®. Gazelle provides affordable, accurate testing to new populations at sites where it is needed most. Hemex designs products for the real world by listening to the needs of providers including those located in remote and challenging settings. Initial tests include sickle cell disease, beta thalassemia, and COVID-19.
Over seven percent of the world’s population is at risk of inheriting hemoglobin disorders, including sickle cell disease (SCD) and beta thalassemia. Early diagnosis could prevent tens of thousands of SCD child deaths each year.
Gazelle Hb Variant is a miniaturized version of the gold standard test known as cellulose acetate electrophoresis. Administration of the test requires minimal training. Results are displayed in 8 minutes, including hemoglobin percentages by type, and can be stored locally or transmitted to the Cloud for patient and disease tracking.
The Gazelle COVID-19 Test is a fluorescent lateral flow immunoassay (FIA) for the qualitative detection of nucleocapsid antigen from COVID-19. The Reader uses advanced imaging and signal-to-noise enhancement techniques to high accuracy.